The possibility that neuronal loss in prion diseases occurs through an
apoptotic process has been postulated and is consistent with the lack
of inflammation in these disorders. In order to test this hypothesis
in FFI, in which neuronal loss is the predominant neuropathological fe
ature, we examined samples of thalamus, basal ganglia, cerebral cortex
, cerebellum and medulla from 10 subjects with FR. All the patients ha
d the characteristic 178 N mutation of the PrP gene. Eight subjects we
re homozygous methionine/melhionine at codon 129 and 2 were heterozygo
us methionine/valine. Apoptotic neurons were identified by in site end
labelling in all the FFI cases and in none of the controls, They were
mostly found in damaged regions and their presence and abundance seem
ed to correlate closely with the neuronal loss, They were particularly
abundant in the thalamus and medullary olives, In heterozygous cases
who had a longer disease duration and more widespread cerebral changes
, apoptotic neurons were also found in the neocortex and striatum. The
abundance of apoptotic neurons also correlated well with microglial a
ctivation as demonstrated by the expression of major histocompatibilit
y complex class II antigens, PrPres immunostaining was almost invariab
ly negative, consistent with previous data showing the lack of obvious
correlation between neuronal loss and PrPres deposits in prion diseas
es.